This article is a Preprint
Preprints are preliminary research reports that have not been certified by peer review. They should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Preprints posted online allow authors to receive rapid feedback and the entire scientific community can appraise the work for themselves and respond appropriately. Those comments are posted alongside the preprints for anyone to read them and serve as a post publication assessment.
COVID-19 Vaccine Hesitancy among the Adult Population in Bangladesh: A Nationally Representative Cross-sectional Survey (preprint)
medrxiv; 2021.
Preprint
in English
| medRxiv | ID: ppzbmed-10.1101.2021.04.23.21255844
ABSTRACT
ABSTRACT Introduction The study related to the COVID-19 vaccine hesitancy is scanty in the context of Bangladesh, despite the growing necessity of understanding the mass people’s vaccination-related behavior. Thus, the present study was conducted to assess the prevalence of the COVID-19 vaccine hesitancy and its associated factors in Bangladesh to fill the knowledge gap. Methodology This study adopted a cross-sectional study design to collect data from 1497 respondents using online (Google forms) and face-to-face interviews. We employed descriptive statistics and multiple hierarchical linear regression analysis. Findings The prevalence of vaccine hesitancy was 41.1%. Men had less hesitancy (β = -0.046, p = 0.030) than women. The Muslims (β = 0.057, p = 0.009) and the respondents living in the city corporation areas (β = 0.132, p <0.001) had more hesitancy. There was significant variation in vaccine hesitancy by administrative divisions (geographic regions). The vaccine hesitancy tended to decrease with increasing knowledge about the vaccine (β = -0.072, p=0.001) and the vaccination process (β= -0.058, p = 0.018). On the other hand, hesitancy increased with the increased negative attitudes towards vaccine (β = 0.291, p <0.001) and conspiracy beliefs towards the COVID-19 vaccine (β = 0.105, p=0.004). The perceived severity of the COVID-19 (β = -0.079, p=0.002) and perceived benefits of COVID-19 vaccination (β = -0.180, p=0.001) were negatively associated with hesitancy, while perceived barriers (β = 0.180, p <0.001) were positively associated. The participants were more hesitant to accept the vaccine from a specific manufacturer. Conclusion This study emphasizes that negative attitudes and conspiracies towards the COVID-19 vaccine should be reduced through effective communications and contracting with additional vaccine manufacturers should be prioritized. The barriers like online registration for receiving the COVID-19 vaccination need to be removed, and initiatives like text message service using the mobile phone operator can be introduced. Highlights About 41% of the respondents had had hesitancy to accept the COVID-19 vaccine. The hesitancy increased with negative attitudes about vaccines and conspiracy beliefs. Perceived barriers to receive the vaccine were increasing vaccine hesitancy. Perceived severity of the COVID-19 decreased the vaccine hesitancy. Perceived benefits of receiving the COVID-19 vaccine decreased the vaccine hesitancy.
Full text:
Available
Collection:
Preprints
Database:
medRxiv
Main subject:
COVID-19
Language:
English
Year:
2021
Document Type:
Preprint
Similar
MEDLINE
...
LILACS
LIS